Cite
APA Citation
Schwabe, C., Illes, A., Ullmann, M., Ghori, V., Vincent, E., Petit-Frere, C., Monnet, J., Racault, A. S., & Wynne, C. (2022). pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial. Expert review of clinical immunology, 18, 533–543. http://access.bl.uk/ark:/81055/vdc_100156411295.0x00000c